ミシガン州における脳腫瘍の臨床試験
ミシガン州内の拠点で、脳腫瘍に関する19件の研究が参加者を募集しています。
ミシガン州内の都市
公式研究テキスト（英語）
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
- Henry Ford Cancer- Detroit, Detroit
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/28更新 · NCT07326566Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
- South Texas Accelerated Research Therapeutics (START) Midwest, Grand Rapids
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/16更新 · NCT05786924A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
- Local Institution - 0119, Ann Arbor
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/16更新 · NCT07492680A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
- University of Michigan Comprehensive Cancer Center, Ann Arbor
- Bronson Battle Creek, Battle Creek
- University of Michigan - Brighton Center for Specialty Care, Brighton
- 他15件
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/15更新 · NCT04511013Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma
- C.S. MOTT Children's Hospital, University of Michigan, Ann Arbor
被験者募集中第2相
59 Months · 全性別 · 2026/09/15更新 · NCT05535166A Phase 1/1b Study of IAM1363 in HER2 Cancers
- University of Michigan, Ann Arbor
- Henry Ford Cancer Institute, Detroit
- START - Midwest Cancer Research Center, Grand Rapids
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/09更新 · NCT06253871Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
- Henry Ford Hospital, Detroit
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/09更新 · NCT05386108Targeted Pediatric High-Grade Glioma Therapy
- C.S. Mott Children's Hospital, Ann Arbor
被験者募集中観察研究
12 Months – 39 Years · 全性別 · 2026/09/08更新 · NCT05839379A First-In-Human, Phase 1 Study Evaluating Oral TACC3 PPI Inhibitor, AO-252, in Advanced Solid Tumors With or Without Brain Metastases
- Karmanos Cancer Institute, Detroit
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/17更新 · NCT06136884Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
- Henry Ford Health System, Detroit
被験者募集中観察研究
全年齢 · 全性別 · 2026/07/22更新 · NCT04427384Virus-Based Gene Therapy (AdV-HSV1-TK and AdV-Flt3L) in Combination With Valacyclovir for the Treatment of Pediatric and Young Adult Patients With Resectable, Recurrent Primary Malignant Brain Tumors
- University of Michigan Comprehensive Cancer Center, Ann Arbor
被験者募集中第1相
3歳〜39歳 · 全性別 · 2026/06/15更新 · NCT06914479Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain Metastases
- University of Michigan Rogel Cancer Center, Ann Arbor
被験者募集中第3相
18歳以上 · 全性別 · 2026/06/09更新 · NCT03550391Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
- C.S. Mott Children's Hospital, Ann Arbor
被験者募集中第2相
12 Months – 39 Years · 全性別 · 2026/05/29更新 · NCT05843253A Study Comparing GLIADEL to Stereotactic Radiosurgery in Metastatic Brain Disease
- Henry Ford, Detroit
被験者募集中第2相
18歳以上 · 全性別 · 2026/04/28更新 · NCT04222062CAR T Cells After Lymphodepletion for the Treatment of IL13Rα2 Positive Recurrent or Refractory Brain Tumors in Children
- C.S. Mott Children's Hospital, University of Michigan, Ann Arbor
被験者募集中第1相
4歳〜25歳 · 全性別 · 2026/03/05更新 · NCT04510051F-Tryptophan PET/CT in Human Cancers
- Karmanos Cancer Institute, Detroit
被験者募集中第1相
18歳以上 · 全性別 · 2026/01/23更新 · NCT05556473Adenovirus Mediated Suicide Gene Therapy With Radiotherapy in Progressive Astrocytoma.
- Henry Ford Health System, Detroit
被験者募集中第1相
18歳以上 · 全性別 · 2025/12/16更新 · NCT05686798Evaluation of the Efficacy of STRATAFIX for Neurosurgical Cranial and Spine Procedures
- University of Michigan Health Sparrow, Lansing
被験者募集中第4相
18歳以上 · 全性別 · 2025/11/05更新 · NCT07225101S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
- Saint Joseph Mercy Hospital, Ann Arbor
- University of Michigan Comprehensive Cancer Center, Ann Arbor
- McLaren Cancer Institute-Bay City, Bay City
- 他16件
被験者募集中第3相
18歳以上 · 全性別 · 2025/10/08更新 · NCT03418961ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。